Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Some drugs can cause changes to your hair.

Understanding drug effects and careful monitoring are crucial for safe and effective dermatology treatments.

The document is a detailed medical reference on skin and genetic disorders.

Pili torti is a rare condition where hair is twisted and breaks easily, often linked to genetic disorders or other health issues.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

A man developed skin issues from cancer medication, which improved with specific treatments.

The conclusion is that a new biopsy technique and humidity chamber help study skin mites better and suggest mite overpopulation may cause skin diseases.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

HDAC inhibitors like Vorinostat and Entinostat may encourage hair regrowth and could be new treatments for hair loss conditions.

Dutasteride and finasteride can change hair growth genes, helping treat hair loss.